ALISA SABSHIN: Open Payments
NPI 1932120060 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 3 payments from 3 companies in 2025. Trend: 2023 $876 · 2024 $234 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $158 |
| Braeburn Inc. | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
Products named: INGREZZA, BRIXADI, COBENFY.
Industry payments across CA — which companies pay providers there.
